درباره این پادکست 🔗
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
میزبان‌ها:
فرکانس به روز رسانی:
every 40 days
میانگین طول صدا:
43 minutes
مصاحبه های مهمان
اسپانسر دارد
پادکست ویدیویی
انگلیسی
ایالات متحده آمریکا
107 قسمت
از سال 16 دسامبر 2017
episodic
در این پادکست 🔗
آخرین اپیزود 🔗
In this episode of The Onco’Zine Brief Peter Hofland talks with Stephen Spellman. Stephen Spellman is Vice President and Senior Scientific Director at Be The Match and the Center for International Blood & Marrow Transplant Research (CIBMTR). Hofland and Spellman talk about the outcomes of a stu…
جستجوی اپیزودهای گذشته
اپیزودهای قبلی The Onco'Zine Brief را جستجو کن.
اپیزود قبلی 🔗
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Ely Benaim, MD, the Chief Medical Officer and Executive Vice President Development at SonALAsense and Mark De Souza, Ph.D, President and Chief Executive Officer of SonALAsense.SonALAsense was founded to create hope in the face of des…
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Jeffery Auletta, MD is Senior Vice President, Patient Outcomes and Experience, National Marrow Donor Program® (NMDP)/Be The Match®.Be The Match® is a global leader in bone marrow transplantation. The organization conducts research to…
In a new episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia.Hofland and Cognetti talk about head and neck cancer and a novel treatment approach called P…
In this episode of The Onco'Zine Brief, Peter Hofland talks with two experts about their research and the impact the outcomes from these studies may have on the treatment of patients diagnosed with cancer.First, Hofland talks with Christopher Heery, MD.Dr Heery is a board-certified medical oncologi…
Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. However, unlike chemotherapy, ADCs are intended to directly target and kill tumor cells while, at the same time sparing normal, healthy cells. Antibody-drug conjugates consist…
In December 2022 the annual meeting of the American Society of Hematology took place in the vibrant city of New Orleans and brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from initial hypothesis to practice-changing…
In the 100th episode of the Onco’Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match. In the program today Hofla…
In this edition of The Onco'Zine Brief, Peter Hofland, Ph.D, talks with Susanna F. Greer, Ph.D. the Chief Scientific Officer of the V Foundation. In her role, Dr. Greer is a visionary ambassador of the V Foundation, who works with the foundation’s Scientific Advisory Committee to steer funding to t…
Despite availability of endocrine therapies for advanced or metastatic breast cancer, there remains a critical unmet need for more effective and convenient treatment options that improve both the patient experience and health outcomes.In today’s episode of The Onco’Zine Brief, Peter Hofland, Ph.D. …
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Peter Hofland است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,820,986و قسمت های195,280,751بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
جستجوی اپیزودهای گذشته
اپیزودهای قبلی The Onco'Zine Brief را جستجو کن.
این پادکست مدعی دارد
This podcast page is claimed and managed by
@hofland
این پادکست به دنبال ... میگردد
اسپانسرها
مهمانان
کمکمجریان
ترفیع متقابل
اگر علاقمندید، لطفاً تماس بگیرید
تولیدکننده این پادکست
See other آگهیهای طبقهبندیشده
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
